BIORESTORATIVE THERAPIES, INC. Share-based Payment Arrangement, Expense
BIORESTORATIVE THERAPIES, INC. (BRTX) reported Share-based Payment Arrangement, Expense of $290.21 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-05-14
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $290.21K, a 85.56% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $447.86K, a 155.01% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $399.93K, a 40.70% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $468.71K, a 44.52% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for fiscal 2025 was $3.33M, a 18.24% increase from fiscal 2024.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for fiscal 2024 was $2.81M, a 63.86% decline from fiscal 2023.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for fiscal 2023 was $7.78M.
- BIORESTORATIVE THERAPIES, INC. share-based payment arrangement, expense for fiscal 2013 was $647.82K, a 42.99% decline from fiscal 2012.
| Period end | Share-based Payment Arrangement, Expense 1 month | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed | Share-based Payment Arrangement, Expense 60 month | Share-based Payment Arrangement, Expense 63 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $290.21K 10-Q · filed 2026-05-14 | $738.08K derived: sum of 2 quarters · filed 2026-05-14 | $1.14M derived: sum of 3 quarters · filed 2026-05-14 | $1.61M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2025-12-31 | $447.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $847.79K derived: sum of 2 quarters · filed 2026-03-26 | $1.32M derived: sum of 3 quarters · filed 2026-03-26 | $3.33M 10-K · filed 2026-03-26 | |||||||
| 2025-09-30 | $399.93K 10-Q · filed 2025-11-12 | $868.64K derived: sum of 2 quarters · filed 2025-11-12 | $2.88M 10-Q · filed 2025-11-12 | $3.05M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2025-06-30 | $468.71K 10-Q · filed 2025-08-12 | $2.48M 10-Q · filed 2025-08-12 | $2.65M derived: sum of 3 quarters · filed 2026-05-14 | $2.94M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2025-03-31 | $2.01M 10-Q · filed 2026-05-14 | $2.18M derived: sum of 2 quarters · filed 2026-05-14 | $2.47M derived: sum of 3 quarters · filed 2026-05-14 | $2.79M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2024-12-31 | $175.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $459.87K derived: sum of 2 quarters · filed 2026-03-26 | $784.19K derived: sum of 3 quarters · filed 2026-03-26 | $2.81M 10-K · filed 2026-03-26 | |||||||
| 2024-09-30 | $284.25K 10-Q · filed 2025-11-12 | $608.57K derived: sum of 2 quarters · filed 2025-11-12 | $2.64M 10-Q · filed 2025-11-12 | $4.10M derived: sum of 4 quarters · filed 2025-11-12 | |||||||
| 2024-06-30 | $324.32K 10-Q · filed 2025-08-12 | $2.35M 10-Q · filed 2025-08-12 | $3.82M derived: sum of 3 quarters · filed 2025-08-12 | $5.31M derived: sum of 4 quarters · filed 2025-08-12 | |||||||
| 2024-03-31 | $2.03M 10-Q · filed 2025-05-14 | $3.49M derived: sum of 2 quarters · filed 2025-05-14 | $4.99M derived: sum of 3 quarters · filed 2025-05-14 | $6.47M derived: sum of 4 quarters · filed 2025-05-14 | |||||||
| 2023-12-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $2.96M derived: sum of 2 quarters · filed 2025-03-28 | $4.44M derived: sum of 3 quarters · filed 2025-03-28 | $7.78M 10-K · filed 2025-03-28 | |||||||
| 2023-09-30 | $1.49M 10-Q · filed 2024-11-12 | $1.49M 10-Q · filed 2023-11-13 | $2.98M derived: sum of 2 quarters · filed 2024-11-12 | $6.32M 10-Q · filed 2024-11-12 | $6.32M 10-Q · filed 2023-11-13 | ||||||
| 2023-06-30 | $1.49M 10-Q · filed 2024-08-13 | $1.49M 10-Q · filed 2023-08-11 | $4.86M 10-Q · filed 2024-08-13 | $4.82M 10-Q · filed 2023-08-11 | |||||||
| 2023-03-31 | $3.38M 10-Q · filed 2024-06-11 | $3.34M 10-Q · filed 2023-05-12 | |||||||||
| 2022-09-30 | $3.07M 10-Q · filed 2023-11-13 | $3.10M 10-Q · filed 2022-11-14 | $6.18M derived: sum of 2 quarters · filed 2023-11-13 | $9.55M 10-Q · filed 2023-11-13 | $9.60M 10-Q · filed 2022-11-14 | ||||||
| 2022-06-30 | $3.10M 10-Q · filed 2023-08-11 | $6.48M 10-Q · filed 2023-08-11 | |||||||||
| 2022-03-31 | $3.38M 10-Q · filed 2023-05-12 | ||||||||||
| 2021-09-30 | $2.90M 10-Q · filed 2022-11-14 | $19.90M 10-Q · filed 2022-11-14 | |||||||||
| 2020-09-30 | $184.77K 10-Q · filed 2021-04-12 | $404.03K derived: sum of 2 quarters · filed 2021-04-12 | $625.91K 10-Q · filed 2021-04-12 | ||||||||
| 2020-06-30 | $219.26K 10-Q · filed 2021-04-12 | $441.14K 10-Q · filed 2021-04-12 | |||||||||
| 2020-03-31 | $221.88K 10-Q · filed 2021-03-29 | ||||||||||
| 2019-09-30 | $234.04K 10-Q · filed 2021-04-12 | $676.85K derived: sum of 2 quarters · filed 2021-04-12 | $1.41M 10-Q · filed 2021-04-12 | ||||||||
| 2019-06-30 | $442.80K 10-Q · filed 2021-04-12 | $1.17M 10-Q · filed 2021-04-12 | |||||||||
| 2019-03-31 | $729.68K 10-Q · filed 2021-03-29 | ||||||||||
| 2015-09-30 | -$24.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | -$1.72K derived: sum of 2 quarters · filed 2015-11-23 | $74.92K 10-Q · filed 2015-11-23 | ||||||||
| 2015-06-30 | $22.50K 10-Q · filed 2015-08-14 | $99.15K 10-Q · filed 2015-08-14 | |||||||||
| 2015-03-31 | $76.65K 10-Q · filed 2015-05-15 | ||||||||||
| 2014-06-30 | $226.33K 10-Q · filed 2015-08-14 | $240.40K 10-Q · filed 2015-08-14 | |||||||||
| 2014-03-31 | $14.07K 10-Q · filed 2015-05-15 | $305.70K 10-Q · filed 2014-05-14 | $2.72M 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $647.82K 10-K · filed 2014-04-11 | $2.42M 10-K · filed 2014-04-11 | |||||||||
| 2013-03-31 | $182.61K 10-Q · filed 2014-05-14 | ||||||||||
| 2012-12-31 | $1.14M 10-K · filed 2014-04-11 | $0.00 10-K · filed 2013-04-02 | |||||||||
| 2011-12-31 | $123.90K 10-K · filed 2013-04-02 | ||||||||||
| 2011-01-31 | $123.90K 10-K · filed 2013-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |